undamentalytics Newsletter
Sign in

Cerus Corp income statement

In fiscal 2025, Cerus Corp reported revenue of $234m, up 16.1% on the year before, operating income of −$8.7m (a -3.7% margin) and net income of −$15.6m, or −$0.08 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue1823333740363439517694114160188187201234254
Cost of revenue———————2023323341——————
Gross profit51012161715111729446073——————
Research and development65781522263134436064646468596860
Selling, general and administrative222223263038464953576667818376768186
Operating income−24−16−16−17−28−45−61−61−58−55−66−58−49−34−30−14−9−2
Interest expense011101223464568987
Income before tax—−17−17−16−43−39−60−63−57−57−71−60−54−42−37−21−15−7
Income tax—00000−404000000000
Net income−24−17−17−16−43−39−56−63−61−58−71−60−54−43−37−21−16−7
Diluted EPS−$0.69−$0.42−$0.35−$0.33−$0.64−$0.61−$0.61−$0.62−$0.56−$0.44−$0.51−$0.37−$0.32−$0.24−$0.21−$0.11−$0.08−$0.04
Diluted shares (average)35m—48m55m68m77m97m102m108m132m140m164m171m177m180m185m191m197m
EBITDA−23−15−15−17−28−43−59−60−56−54−64−55−46−31−27−12−7−1

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CERS vs LMATCERS vs ESTACERS vs KIDSAXGN vs CERS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Cerus Corp's SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cerus Corp.